Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tirzepatide Titration to Reduce Side Effects (TiTRE) in Individuals With Obesity

NCT07574723 is registered in ClinicalTrials.gov with Dasman Diabetes Institute as lead sponsor.

NCT NCT07574723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07574723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tirzepatide Titration to Reduce Side Effects (TiTRE) in Individuals With Obesity
Lead sponsor
Dasman Diabetes Institute
Phase
Not applicable
Overall status
Recruiting
Start date
May 15, 2026
Completion date
December 31, 2029
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity